The Early Atherosclerotic Lesion — Morphology and Mechanisms

Pooling project group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events — final reporting of the pooling project. J Chron Dis 1978; 31: 201–306.

Keys A. Seven Countries: Death and coronary heart disease. Cambridge: Harvard University Press, 1980.

Böttiger L-E Carlson LA . Risk factors for ischaemic vascular death for men in the Stockholm prospective study Atherosclerosis 1980; 36: 389–408.

Hopkins PN Williams RR . A survey of 246 suggested coronary risk factors Atherosclerosis 1981; 40: 1–52.

Lipid Research Clinic Program. The lipid research clinics coronary primary prevention trial results: I. Reduction in incidence of coronary heart disease. J Am Med Assoc 1984; 251: 351–64.

Vlodaver Z Kahn HA Neufelt HN . The coronary arteries in early life in three different ethnic groups. Circulation 1969; 39: 541–50.

Rapola J Pesonen E. Coronary artery changes in newborn babies. APMIS (Copenhagen) 1977; 85: 286–96.

Velican C Velican D. The precursors of coronary atherosclerotic plaques in subjects up to 40 years old. Atherosclerosis 1980; 37: 33–46.

Gown AM Tsukada T Ross R. Human atherosclerosis. II: Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986; 125: 191–207.

Aqel NM Ball RYT Waldmann H Mitchinson MJU . Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J Pathol 1985; 146: 197–204.

Jonasson L Holm J Skalli O Bondjers G Hansson GK . Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6: 131–38.

Mosse PRL Campbell GR Wang ZL Campbell JH . Smooth muscle phenotypic expression in human carotid arteries. I: Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 1985; 53: 556–62.

Campbell GE Chamley-Campbell JH . The cellular pathobiology of atherosclerosis. Pathology 1981; 13: 423–40.

Thyberg J Palmberg L Nilsson J Ksiazek T Sjöolund M. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation 1983; 25: 156–67.

Hansson G Holm J Jonasson L. Detection of activated T lymphocytes in the human atherosclerosic plaque. Am J Pathol 1989; 135: 169–75.

Holme I Enger SC Helgeland A . Risk factors and raised lesions in coronary and cerebral arteries. Statistical analysis from the Oslo study. Arteriosclerosis 1981; 1: 250–56.

Solberg LA Strong JP . Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 1983; 3: 187–98.

Masuda J Ross R. Atherogenesis during low level hypercholesterolemia in the non-human primate. I: Fatty streak formation. Arteriosclerosis 1990; 10: 164–77.

Schwenke DC Carew TE . Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I: Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 1989; 9: 895–907.

Schwenke DC Carew TE . Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II: Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 1989; 9: 908–18.

Walker L Reidy M Bowyer D. Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. Am J Pathol 1986; 125: 450–59.

Masuda J Ross R. Atherogenesis during low level hypercholesterolemia in the non-human primate. II: Fatty streak conversion to fibrous plaque. Arteriosclerosis 1990; 10: 178–87.

Gerrity R. The role of monocytes in atherogenesis. I: Transition of blood-borne monocytes into foam cells in fatty streaks. Am J Pathol 1981; 103: 181–90.

Rosenfelt ME Tsukada T Gown AM Ross R. Fatty streak initiation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1987; 7: 9–23.

Joris I Zand T Nunnari JJ Krolikowski FJ Majno G. Studies on the pathogenesis of atherosclerosis. I: Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol 1983; 113: 341–58.

Jerome WG Lewis JC . Early atherogenesis in White Carneau pigeons. II: Ultrastructural and cytochemical observations. Am J Pathol 1985; 119: 210–22.

Faggiotto A Ross R Harker L. Studies of hypercholesterolemia in the nonhuman primate. I: Changes that lead to fatty streak formation. Arteriosclerosis 1984; vmr-4: 323–40.

Faggiotto A Ross R. Studies of hypercholesterolemia in the nonhuman primate. II: Fatty streak conversion of fibrous plaque. Arteriosclerosis 1984; vmr-4: 341–56.

Alderson LM Endemann G Lindsay S. Pronczuk A Hoover R Hayes KC . LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol 1986; 123: 334–42.

Territo MC Berliner JA Almada L Ramirez R Fogelman AM . β-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Arteriosclerosis 1989; 9: 824–28.

Quinn MT Parthasarathy S Fong LG Steiberg D. Oxidatively modified low density lipoprotein: A potential role in recruitment and retention of monocytes/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84: 2995–98.

Cushing SD Berliner JA Valente AJ . Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990; 87: 5134–38.

Berliner JA Territo MC Sevanian A . Minimally modified low density lipoptotein stimulates monocyte endothelial interactions. J Clin Invest 1990; 85: 1260–66.

Frostegård J Haegerstrand A Gidlund M Nilsson J. Biologically modified low density lipoprotein increases the adhesive properties of endothelial cells. Atherosclerosis 1991; 90: 119–26.

Springer T. Adhesion receptors in the immune system. Nature 1990; 346: 425–34.

Patarroya M Prieto J Rincon J . Leukocyte-cell adhesion: A molecular process fundamental in leukocyte physiology. Immunol Rev 1990; 114: 68–108.

Thornhill M Wellicome S Mahiouz D Lanchbury J Kyan-Aung U Haskard D. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial adhesiveness for T cells. The contribution of vascular cell adhesion molecule-dependent and independent binding mechanisms. J Immunol 1991; 146: 592–98.

Cybulsky M Gimbrone M. Endothelial expression of a mononuclear adhesion molecule during atherogenesis. Science 1991; 251: 788–91.

Brown MS Basu SK Falck JR Ho YK Goldstein JL . The scavenger cell pathway for lipoprotein degradation. Specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramol Struct 1980; 13: 67–81.

Henriksen T Mahoney EM Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 1981; 78: 6499–503.

Steinbrecher UP Parthasarathy S Leake DS Witztum JL Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 83: 3883–87.

Heinecke JW Rosen H Chait A. Iron and copper promote modification of low density lipoprotein by smooth muscle cells in culture. J Clin Invest 1987; 74: 1890–94.

Morel DW DiCorleto PE Chisolm GM . Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; vmr-4: 357–64.

Parthasarathy S Printz DJ Boyd D Joy L Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986; 6: 505–10.

Cathcart MK Morel DW Chisholm GM . Monocytes and neutrophilis oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol 1987; 38: 341–50.

Sparrow CP Parthasarathy S Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not aceltylated low density lipoprotein. Biol Chem 1988; 264: 2599–604.

Arai H Kita T Yokode M Narumiya S Kawai C. Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: Different uptake mechanisms for acetylated and oxidized low density lipoproteins. Biochem Biophys Res Commun 1989; 159: 1375–82.

Kodama T Freeman M Rohrer L Zabrecky J Matsudaira P Krieger M. Type 1 macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 1990; 343: 531–35.

Rohrer L Freeman M Kodama T Penman M Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 1990; 343: 570–72.

Matsumoto A Naito M Itakura H . Human macrophage scavenger receptor: Primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 1990; 87: 9133–37.

Halliwell B Gutteridge MC . Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 214: 1–14.

Wiztum JL Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785–92.

Haberland ME Fong D Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipemic rabbits. Science 1988; 241: 215–18.

Palinsky W Rosenfeld ME Ylä-Herttuala . Low density lipoprotein undergoes modification in vivo. Proc Natl Acad Sci USA 1989; 86: 1372–76.

Rosenfeld ME Palinski W Ylä-Herttuala S Butler S Witztum JL . Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990; 10: 336–49.

Ylä-Herttuala S Palinsky W Rosenfeld ME . Evidence for presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086–85.

Munro JM van der Walt JD Munro CS Chalmers JAC Cox EL . An immunohistochemical analysis of human aortic fatty streaks. Human Pathol 1987; 18: 375–80.

Emeson EE Robertson AL . T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 1988; 130: 369–76.

Hemler ME Glass D Coblyn JS Jacobson JG . Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. J Clin Invest 1986; 78: 696–702.

Hansson GK Jonasson L Holm J Claesson-Welsh L. Class II MHC antigen expression in the atherosclerotic plaque: Smooth muscle cells express HLA-DR, HLA-DQ, and the invariant gamma chain. Clin Exp Immunol 1986; 64: 261–68.

Hansson GK Jonasson L Seifert PS Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989; 9: 567–78.

Hansson GK Bondjers G Nilsson LA . Plasma protein accumulation in injured endothelial cells. Immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. Exp Mol Pathol 1979; 30: 12–26.

Hansson GK Bondjers G Bylock A Hjalmarsson L. Ulirastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and non-atherosclerotic rabbits. Exp Mol Pathol 1980; 33: 302–15.

Vlaicu R Niculescu F Rus H Cristea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 1985; 57: 163–77.

Cerilli J Brasile L Karmody A. Role of vascular endothelial antigen system in the etiology of atherosclerosis. Ann Surg 1985; 202: 329–34.

Hamsten A Björkholm M Norberg R de Faire U Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet 1986; i: 113–16.

Benditt EP Barrett T McDougall JM . Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80: 6386–89.

Frostegård J Wu R Giscombe R Holm G Levert AK Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Throm 1992 (in press).

Ross R Raimes EW Bowen-Pope DF . The biology of platelet-derived growth factor. Cell 1986; 46: 155–69.

Heldin C-H Wasteson A Westermark B. Platelet-derived growth factor. Mol Cell Endocrinol 1985; 39: 169–87.

Hart CE Forstrom JW Kelly JD . Two classes of PDGF receptors recognize different isoforms of PDGF. Science 1988; 240: 1529–31.

Heldin C-H Bäckstöm G Östman A . Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types. Eur Mol Biol Org J 1988; 7: 1387–93.

Claesson-Welsh L Eriksson A Moren A . cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cel Biol 1988; 8: 3476–86.

Claesson-Welsh L Eriksson A Westermark B Heldin C-H. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF receptor. Proc Natl Acad Sci USA 1989; 86: 4917–21.

Yarden Y Escobedo JA Kuang W-J . Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 1986; 323: 226–32.

Nilsson J Ksiazek T Heldin C-H Thyberg J. Demonstration of stimulatory effects of platelet-derived growth factor on arterial smooth muscle cells: Difference between cells from young and adult animals. Exp Cell Res 1983; 145: 231–37.

Narayanan AS Page R. Biosynthesis and regulation of type V collagen in diploid human fibroblasts. J Biol Chem 1983; 258: 11694–99.

Grotendorst GR Chang T Seppä H Kleinman HK Martin GR . Platelet-derived growth factor is chemotactic for vascular smooth muscle cells. J Cell Physiol 1982; 113: 261–66.

Habenicht AJR Glomset JA King WC Nist C Mitchell CD Ross R. Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 1981; 256: 12329–35.

Habenicht AJ Dresel HA Goerig M . Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3T3 cells stimulated by platelet derived growth factor. Proc Natl Acad Sci USA 1986; 83: 1344–48.

Ross R Glomset JA . The pathogenesis of atherosclerosis N Engl J Med 1976; 295: 369–77, 420–25.

Waterfield MD Scrace GT Whittle N . Platelet-derived growth factor is structurally related to the putative transforming protein p28^si8 of simian sarcoma virus. Nature 1983; 304: 35–39.

Doolittle RF Hunkapiller MW Hood LE . Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 1983; 221: 275–77.

Seifert RA Schwartz SM Bowen-Pope DF . Developmentally regulated production of platelet-derived growth factor-like molecules. Nature 1984; 311: 669–71.

Nilsson J Sjölund M Palmberg L Thyberg J Heldin C-H. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci USA 1985; 82: 4418–22.

Libby P Warner SJC Salomon RN Birinyi LK . Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 1988; 318: 1493–98.

Bowen-Pope DF Vogel A Ross R. Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci USA 1984; 81: 2396–400.

Barrett TB Gajdusek CM Schwartz SM McDougall JK Benditt EP . Expression of the sis gene by endothelial cells in culture and in vivo. Proc Natl Acad Sci USA 1984; 81: 6772–74.

Shimokado K Raines EW Madtes DK Barrett TB Benditt EP Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985; 343: 277–86.

Ross R. The pathogenesis of atherosclerosis — an update. N Engl J Med 1986; 314: 488–500.

Nilsson J. Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis 1986; 62: 185–99.

Burgess WH Maciag T. The heparin-binding family of growth factors. Ann Rev Biochem 1989; 58: 575–606.

Winkles JA Freisel R Burgess WH . Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 1987; 84: 7124–28.

Schweigerer L Neufeld G Friedman J Abraham JA Fiddes JC Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257–59.

Klagsburn M Edelman ER . Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis 1989; 9: 269–78.

McNeil PL Muthukrishnan L Warder E D'Amore P. Growth factors are released by mechanically wounded endothelial cell J Cell Biol 1989; 109: 811–22.

Besner G Higashiyama S Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul 1990; 1: 811–19.

Higashiyama S Abraham JA Miller J Fiddes JC Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936–39.

Dinarello CA . An update on human interleukin 1: From molecular biology to clinical relevance. J Clin Immunol 1985; 5: 287–97.

Raines E Dower S Ross R. Interleukin 1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243: 393–96.

Ikeda U Ikeda M Oohara T Kano S. Yaginuma T. Mitogenic action of interleukin 1 α on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 1990; 84: 183–88.

Libby P Ordovas JM Birinyi LK Auger KR Dinarello CA . Inducible interleukin 1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432–38.

Beutler B Cerami A. Cachetic and tumour necrosis factor as two sides of the same biological coin. Nature 1985; 320: 584–88.

Warner SJC Libby P. Human smooth muscle cells. Target and source of tumour necrosis factor. J Immunol 1989; 142: 100–109.

Barath P Fishbein M Cao J Berenson J Helfant R Forrester J. Tumour necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 1990; 137: 503–509.

Hollenberg S Cunnion R Parrillo J. The effect of tumour necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings. Chest 1991; 100: 1133–37.

Cornelius P Enerbäck S Bjursell G Olivecrona T. Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. Biochem J 1986; 249: 765–69.

Sporn MB Roberts AB Wakefield LM de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor β. J Cell Biol 1987; 105: 1039–45.

Battegay E Raines E Seifert R Bowen-Pope D Ross R. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515–27.

Trinchieri G Perussia B. Immune interferon: A pleitropic lymphokine with multiple effects. Immunol Today 1985; 6: 131–35.

Hansson GK Hellstrand M Rymo L Rubbia L Gabbiani G. Interferon γ inhibits both proliferation and expression of alpha smooth muscle action in arterial smooth muscle cells. J Exp Med 1989; 170: 1595–608.

Amento E Ehsani N Palmer H Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991; 11: 1223–30.

Geisterfer AA Peach MJ Owens GK . Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic rat smooth muscle cells. Circ Res 1988; 62: 749–56.

Bobik A Grinpukel S Little PJ Grooms A Jackman G. Angiotensin II and noradrenalin increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle. Biochem Biophys Res Commun 1990; 166: 580–88.

Naftilan AJ Pratt RE Dzau VJ . Induction of platelet-derived growth factor A-chain and c-myc gene expressonis by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1419–24.

Fischer-Dzoga K Wissler RW . Stimulation of proliferation in stationary primary cultures of monkey aortic smooth muscle cells. Part 2: Effect of varying concentration of hyperlipemic serum and low density lipoproteins of varying dietary fat origins. Atherosclerosis 1976; 24: 515–25.

Koschinsky T Bünting CE Rütter R Gries FA . Increased growth stimulation of human vascular cells by serum from patients with primary hyper-LDL-cholesterolemia. Atherosclerosis 1987; 63: 7–13.

Oikawa S Hori S Sano R . Effect of low density lipoprotein on DNA synthesis of cultured arterial smooth muscle cells. Atherosclerosis 1987; 64: 7–12.

Libby P Miao P Ordovas JM Schaefer EJ . Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol 1985; 124: 1–8.

Hahn AW Ferracin F Buhler F Pletscher A. Modulation of gene expression by high and low density lipoprotein in human vascular smooth muscle cells. Biochem Biophys Res Commun 1991; 178: 1465–71.

Stiko-Rahm A Hultgårdh-Nilsson A Rengström J Hamsten A Nilsson J. Oxidized and native LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human arterial smooth muscle cells Arterioscler Thromb 1992 (in press).

Fox PL DiCorleto PE . Modified low density lipoproteins suppress production of a platelet-derived growth factor-like protein by cultured endothelial cells. Proc Natl Acad Sci USA 1986; 83: 4774–78.

Maiden LT Chait A Raines EW Ross R. The influence of oxidatively modified low density lipoproteins on expression of platelet derived growth factor in human monocyte-derived macrophages. J Biol Chem 1991; 266: 13901–907.

Hamilton TA Ma GP Chisholm GM . Oxidized low density lipoprotein suppresses the expression of tumour necrosis factor α mRNA in stimulated murine perotoneal macrophages. J Immunol 1990; 144: 2343–50.

Pfeifle B Boeder H Ditschuneit H. Interaction of receptors for insulin like growth factor I, platelet derived growth factor and fibroblast growth factor in rat aortic cells. Endocrinology 1987; 120: 2251–58.

Gospadorowicz D Hirabayashi K Giguere L Tauber JP . Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture. J Cell Biol 1981; 89: 458–78.

Nilsson J von Euler AM Dalsgaard C-J. Stimulation of connective tissue cell growth by the neuropeptides substance P and substance K. Nature 1985; 315: 61–63.

Komuro I Kurihara H Takaku F Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249–52.

Gerrity RG Cliff WJ . The aortic tunica media of the developing rat. I: Quantitative stereologic and biochemical analysis. Lab Invest 1975; 32: 585–600.

Nikkari ST Rantala I Pystynen P Nikkari T. Characterization of the phenotype of smooth muscle cells in human fetal aorta on the basis of ultrastructure, immunofluorescence, and the composition of cytoskeletal and cytocontractile proteins. Atherosclerosis 1988; 74: 33–40.

Ross R Wight TN Strandness E Thiele B. Human atherosclerosis. I: Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984; 114: 79–93.

Thyberg J Nilsson J Palmberg L Sjölund M. Adult human arterial smooth muscle cells in primary culture. Modulation from contractile to synthetic phenotype. Cell Tissue Res 1985; 239: 69–74.

Campbell GR Campbell JH . Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985; 42: 139–62.

Hedin U Bottger BA Forsberg E Johansson S Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 1988; 107: 307–19.

Hultgårdh-Nilsson A Krondahl U Querol-Ferrer V Ringertz NR . Differences in growth factor response in smooth muscle cells isolated from adult and neonatal rats. Differentiation 1991; 47: 99–105.

Björkerud S. Separation of arterial smooth muscle cell populations with different growth patterns. APMIS (Copenhagen) 1984; 92: 293–301.

Schwartz SM Foy L Bowen-Pope DF Ross R. Derivation and properties of platelet derived growth factor independent rat smooth muscle cells. Am J Pathol 1990; 136: 1417–28.

Björkerud S Bondjers G. Arterial repair and atherosclerosis after mechanical injury. Part 5: Tissue response after induction of a large superficial transverse injury. Atherosclerosis 1973; 18: 235–55.

Ferns GAA Reidy MA Ross R. Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes. Am J Pathol 1991; 138: 1045–57.

Stemerman MB Ross R. Experimental arteriosclerosis. I: Fibrous plaque formation in primates, an electron microscope study. J Exp Med 1972; 136: 769–89.

Clowes A Schwartz SM . Significance of quiescent smooth muscle cell migration in the injured rat carotid artery. Circ Res 1985; 56: 139–45.

Clowes AW Reidy MA Clowes MM . Mechanisms of stenosis after arterial injuiry. Lab Invest 1983; 49: 208–15.

Reidy MA Silver M. Endothelial regeneration VII: Lack of intimal proliferation after defined injury to rat aorta. Am J Pathol 1985; 118: 173–77.

Fingerle J Johnson R Clowes AW Majesky MW Reidy MA . Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 1989; 86: 8412–16.

Majesky MW Reidy MA Bowen-Pope DF Hart CE Wilcox JN Schwartz SM . PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990; 111: 2149–58.

Majesky M Lindner V Twardzik D Schwartz S Reidy M. Production of transforming growth factor β during repair of arterial injury. J Clin Invest 1991; 88: 904–10.

Cercek B Fishbein MC Forrester JS Helfant RH Fagin JA . Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 1990; 66: 1755–90.

Lindner V Lappi D Baird A Majack R Reidy M. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106–13.

Ferns GA Raines EW Sprugel KH Motani AS Reidy MA Ross R. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129–32.

Barrett TB Benditt EP . sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci USA 1987; 84: 1099–103.

Barrett TB Benditt EP . Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988; 84: 2810–14.

Wilcox JN Smith KM Williams LT Schwartz SM Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988; 82: 1134–43.

Nelken N Coughlin S Gordon D Wilcox J. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121–27.

Wang AM Doyle MV Mark DF . Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 9717–21.

Carew TE Schwenke DC Steinberg D. Antiatherogenic effects of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic (WHHL) rabbit. Proc Natl Acad Sci USA 1987; 84: 7725–29.

Kita T Nagano Y Yokode M . Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987; 84: 5928–31.

Bjöorkhem I Henriksson-Fryschuss A Breuer O Ficzfalusy U Berglund L Henriksson P. The antioxidant buylated hyroxytoluene protects against atherosclerosis. Arterioscler Thromb 1991; 11: 15–22.

Riemersma RA Wood DA Macintyre CCA Elton RA Gey KF Oliver MF . Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1–5.

Esterbauer H Striegl G Puhl H Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6: 67–75.

Regnström J Tornvall P Landou C Hamsten A. Angiographic evidence for an association between susceptibility to low density lipoprotein oxidation and coronary atherosclerosis. Lancet 1992; 339: 1183–86.